Aiocd Pharma Limited, a active public limited company, was established on 16 October 2006 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH2006PLC165149. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹76.00 Cr and a paid-up capital of ₹27.47 Cr.
Formerly known as Maharashtra Safe Chemists And Distributors Alliance Limited. It upholds a compliant status. Employing 42 professional, Its leadership includes Devesh Amubhai Pathak (Director), Jagannath Sakharam Shinde (Director), Ravindra Raigonda Patil (Cfo). Past directors included Madan Krishnarao Patil, Devesh Amubhai Pathak, Ravindra Manohar Savant. Its latest AGM occurred on 20 December 2024, with the balance sheet filed on 31 March 2024. It is based at 6Th Floor, Corporate Park-Ii, V.N. Purav Marg, Chembur,, Mumbai, Maharashtra, 400071.
U24239MH2006PLC165149
165149
16 October 2006
₹76.00 Cr
₹27.47 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Aiocd Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devesh Amubhai Pathak | Director | 28 Aug 2019 | Current |
| Jagannath Sakharam Shinde | Director | 16 Oct 2006 | Current |
| Ravindra Raigonda Patil | Cfo | 11 Feb 2022 | Current |
| Prasad Waman Danave | Managing Director | 30 Sep 2020 | Current |
| Ravindra Bajirao Pawar | Director | 08 Dec 2021 | Current |
| Vijay Pandurang Patil | Director | 15 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jun 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Oct 2019 | Past |
| Pramod Abcsdd | Director | 30 Mar 2012 | Past |
| Pramod Abcsdd | Director | 19 Mar 2013 | Past |
| Pramod Abcsdd | Director | 20 Aug 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aiocd Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.03% increase. The company also saw a slight decrease in profitability, with a 9.74% decrease in profit. The company's net worth moved up by a moderate rise of 1.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aiocd Pharma had a promoter holding of 1.32% and a public holding of 98.68%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aiocd Pharma has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aiocd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aiocd Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aiocd Pharma Limited last Annual general meeting of members was held on 20 Dec 2024 as per latest MCA records. was documented.
The activity Aiocd Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Jashvant Patel Prahladbhai was appointed as a Director was appointed as a Director on 13 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
Progress on Vaijanath Eknath Jagushte was appointed as a Director was appointed as a Director on 13 Sep 2023 & has been associated with this company since 2 years 3 months . was documented.
The activity Raveendran Balkrishnan was appointed as a Director was appointed as a Director on 13 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
Basavraj Channappa Manure was appointed as a Director was appointed as a Director on 02 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The CIN of Aiocd Pharma Limited is U24239MH2006PLC165149.
Aiocd Pharma Limited is headquartered at 6Th Floor, Corporate Park-Ii, V.N. Purav Marg, Chembur,, Mumbai, Maharashtra, 400071.
Aiocd Pharma Limited was incorporated on 16 October 2006.
The current directors of Aiocd Pharma Limited are
The primary industry of Aiocd Pharma Limited is Trade.
Aiocd Pharma Limited is unlisted.
The authorized capital of Aiocd Pharma Limited is ₹76.00 Cr, and the paid-up capital is ₹27.47 Cr.
The compliance status of Aiocd Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX